Health Archive » August, 2009

Health - August, 2009

182 articles

• Walgreen Hits Cephalon Over Provigil Generic Deals
• Miss. AG Hits Teva, Other Pharmas With AWP Suit
• Wyeth Employees' Don, Doff Suit Moves To Trial
• CVS, Others Hit With Suit Over Generics Prices
• Ethicon Loses Bid To Toss Faulty Stapler Suit
• SEC Fraud Claims Against Ex-Centerpulse Exec Pared
• Wholesaler Denied JMOL In Suit Over Sanofi's Arava
• Boehringer IP Atty's Forced Retirement Ruled Illegal
• Derivative Suit Against Cephalon Board, CEO Tossed
• Zimmer, Smith Nephew Settle Bone Screw Patent Spat
• Upcoming HHS/OCR Breach Notification Requirements
• Defunct La. Hospital Slams Insurer With $59M Suit
• Judge Keeps Neurontin Case Against Pfizer Intact
• 6th Circ. Affirms Dismissal Of Fen-Phen Case
• 7th Circ. Remands $37M Fine For Weight-Loss Guru
• Zimmer Slapped With Patent Suit Over Prosthetic Hips
• Bausch Wins Bid To Boot Expert From ReNu MDL
• FDA's Head Of Medical Devices Steps Down
• FDA Lacks Data To Back Funding Requests: Report
• Experts Call FDA's Device Approval Process Flawed
• Digitek Plaintiffs Must Produce Info
• Health Insurance Price-Fixing Suits Merged Into MDL
• FDA Restricts Clinical Trial Review Board Over Safety
• Mass. AG Accuses Mylan, Others Of Medicaid Fraud
• Kaiser, Project Managers Settle FLSA Suit For $1.4M
• Fed. Circ. Revives Part Of Ortho-McNeil Ultracet Saga
• Mallinckrodt Damages Limited In E-Z-EM Injector Spat
• Punitive Damages Bid Tossed In ObTape MDL
• 2nd Circ. Hands GSK A Win In Avandia Securities Suit
• Wyeth Loses Bid To Oust Howrey From Stent Suit
• FDA Reviewing Safety Of Popular Weight-Loss Drug
• Cipro Pay-For-Delay Deal Was Within Calif. Law: Court
• Allergan Warning May Prompt Suits By AGs: Expert
• HP, Others Sued Over Videoconferencing Patent
• Calif. Pharmacies Sue Pfizer Over Wyeth Merger
• Radiologist Targets Abbott Labs Over Stent Patent
• Citigroup Argues KV Pharma Knew ARS Risks
• Boston Scientific Stent Patent Spat Booted From Del.
• 3 Classes OK'd In Cosmetic Clinic Workers' OT Suit
• Warner Chilcott To Buy P&G Drug Biz For $3.1B
• Medtronic, WL Gore Settle Stent Patent Dispute
• Quebec Judge Rejects Class Action For Paxil Claims
• Qualitest Recalls Two Lots Of Insulin Syringes
• Nutracoastal Recalls, Stops Distributing 'Steam'
• Fed. Circ. To Revisit Ariad, Lilly IP Dispute En Banc
• Antitrust Claims Nixed In Dialysis Clinics' Contract Spat
• LadaTech Sues Illumina Over DNA Analysis Patent
• Maximizing Biotech Patent Protection On A Budget
• Biovail's Hedge Fund Fraud Suit Gets Tossed
• Lilly To Pay $22.5M To Settle W.Va. Zyprexa Claims
• 9th Circ. Rejects Rehearing On Norvir Antitrust Deal
• New Ill. Ethics Rules For 'Reporting Up'
• Rite Aid, CVS Hit Cephalon With New Provigil Suit
• MediciNova, Avigen Merge To Boost Ibudilast Efforts
• No Brand Drugs For Iowa Medicaid Patients: 8th Circ.
• Plaintiffs To Appeal NY Ruling Over ReNu Solution
• FDA Warns Cos. About Marketing Ibuprofen Products
• Doctor's Deposition To Be Shown In Fosamax Trial
• Court Won't Change Inventorship In Zicam IP Suit
• Viagra MDL Plaintiffs Lose Star Expert Witness
• Bayer Dealt Blow In Nexavar Feud With Cipla
• Method Patents Not Covered By 271(f): Fed. Circ.
• Merck Wins Block On Teva's Generic Singulair
• Merck Seeks To Toss Doctor's Fosamax Testimony
• 5th Circ. Unsure Of Jurisdiction For Aetna Suit
• Neuralstem Asks Judge To Rethink Trade Libel Ruling
• Medicis Clears Up Acne Drug Dispute With Sandoz
• Health Fund Takes Seroquel Fraud Suit To 11th Circ.
• Synergetics Can't Claim Price Coercion In Alcon Suit
• Mylan Fights Decision Blocking Generic Benicar
• Communicating Effectively When Bad News Breaks
• USPTO Grants Apotex's Bid To Review Plavix Patent
• Medtronic Units Appeal Globus Patent Judgment
• Eli Lilly Method Patent For Gemzar Found Invalid
• Fen-Phen Atty Holds On To $5.7M Arbitration Award
• Drug Co-Op Accuses Boehringer Of Mirapex Monopoly
• Novo Fights To Nix Counterclaims In Prandin IP Suit
• The DOJ Stance On Reverse Payment Settlements
• Ex-Lawyers Get 20, 25 Years In Fen-Phen Fraud Case
• Purdue Pharma's Ultram Patents Deemed Invalid
• High Court Asked To Limit Juries' Role In Patent Suits
• Bayer Sues J&J Unit Over Arthritis Drug
• Sanofi Appeal Puts Hospira's Generic Eloxatin On Hold
• Hospira Recalls Medical Devices For Faulty AC Cords
• Align Settles Orthodontics Patent War In $90M Deal
• GSK Sues Glenmark Over Malarone Patents
• Barr Recalls Oversized Adderall Batch
• Judge Greenlights Aredia Cases Against Novartis
• Science Cos. Clash Over Failed Spine Screw Deal
• TET, Pharmasset Settle Spat Over Gene Test Patent
• Kappos Promises To Reform USPTO
• Rite Aid, CVS File New HIV Drug Price Complaint
• Post-Claim Underwriting: Calif.'s Dirty Secret
• NJ Judge Rejects 2nd Attempt To Certify Vioxx Action
• FDA Clears Mylan Over Ignored Computer Warnings
• Schering Prevails In Patent Suit Over Pig Vaccine
• Antitrust Suit Says Merck Blocking Generic Singulair
• Medline Sues 3M Over Hand Scrub Ads
• Demand For The Patented Product — Lower Bar?
• Class Cert. For 20K Nurses Sought In Wage Case
• Covington Snags Ala. Atty Who Won Vioxx Suits
• Miller Canfield Picks Up Pfizer Patent Expert
• 1st Circ. Revives Qui Tam Claims Over Procrit AWP
• Sanofi, Watson Resolve Patent Dispute Over Plavix
• Opening Salvo Fired In Fosamax Trial
• Schering, Orchid Settle Clarinex Patent Suit
• Magistrate Pushes To Keep Iovate Patent Suit Alive
• Expert Testimony Excluded Again In Accutane MDL
• NuvaRing Maker Ordered To Pay E-Discovery Costs
• Merck Swaps Lead Attorney For Vioxx Appeal
• Judge OKs $925M UnitedHealth Deal, Slashes Fees
• Cordis Stent Patents Found Enforceable On Remand
• Plaintiffs Reload In Cephalon Antitrust Litigation
• Ill. Enacts New Green Laws For Water, Drugs
• Obama Vows To Speed Generic-Drug Access
• Wellbutrin Plaintiffs Step Up Fight For Docs' Release
• Bloomberg Wins Bid To Unseal Seroquel Docs
• Judge Won't Dismiss Mich. Blue Cross ERISA Suit
• Abbott Sues Centocor Over Psoriasis Drug Patents
• Judge Upholds Expanded Discovery In Digitek Case
• Watson Recalls Fentanyl Patches Due To Leak Risk
• Optometrist Makes Antitrust Claims In CIBA IP Suit
• FDA Speeds Up Disciplining Of Wayward Researchers
• Ariz. Nurses Seek Class Reconsideration In Cartel Suit
• Silicon Valley Venture Capital Survey Shows Weak Q2
• Medical Device Maker Sued For Infringement, Libel
• Revisiting Ariad V. Eli Lilly
• Surgical Appliances Hit With Breast Prosthesis IP Suit
• Miss. AG's Suit Ousted From Vitamin MDL
• Bilski Test Stifles Innovation Across Industries: Briefs
• Subpoena Of Scientist Quashed In Fosamax MDL
• Zyprexa Failure-To-Warn Suit Survives In MDL
• FTC Seeks More Info On Watson, Arrow Merger
• Texas MDL Panel Consolidates Mylan Cases
• Insurer Ordered To Cover ORI In Amputated Toes Suit
• Class Cert. Denied In Suit Over Bayer's WeightSmart
• Court Approves $10M Settlement In Norvir Pricing Suit
• Schering-Plough Denied Injunction In Sunscreen Suit
• Wyeth, Pfizer Resolve Investor Suits Over Merger
• Bilski Test Too Tough On Patent Eligibility: Briefs
• Organon Loses Bid To Nix NuvaRing Complaint
• Teva Sues Merrill Over ARS Gone Bad
• Mayer Brown Snags Fish & Richardson IP Partner
• Elan Sues Over Biogen Objection To $1B J&J Deal
• Jury Hands Medtronic $57M In Alloy Suit Against AGA
• FDA Urges Melamine Testing On Drug Products
• India To Launch WTO Battle Over EU Drug Seizures
• Antitrust Law Can't Touch State Hospice Regs: Wash.
• FDA Head Promises Enforcement Crackdown
• C&D Appeals $29.2M Award In Pregnancy Test Suit
• Investors Hit Spectranetics With Fraud Suit
• Fed. Circ. Affirms Invalidity Of Bayer's Yasmin Patent
• Abbott To Try For Summary Judgment In TriCor Suit
• Merck, Schering Offer $42M To Settle Vytorin Suits
• Covidien Loses Bid To Block Generic Restoril
• J&J Unit Eyed Over Clinical Reviewers
• StemCells Claims Survive In Libel Suit Over IP Spat
• Revamping The False Claims Act
• FDA Orders Cancer Warning For TNF Blockers
• Navinta Infringed Abraxis' Naropin Patents: Judge
• ICU, Medegen Settle IV Connection Patent Spat
• Daiichi Earns Win Against Mylan Over Benicar Patent
• 9th Circ. Affirms NLRB Ruling In Hospital OT Spat
• Clarifying Time Limits For Follow-On Damages Claims
• Osteotech, RTI Near Deal In Bone Cleaning IP Suit
• Merck To Pay $80M To Settle Vioxx Suits
• J&J Hits CIBA Vision Over Contact Lens Patents
• FDA Halts Production Of Teva Animal Drugs
• Digitek MDL Claims Survive Motions To Dimiss
• India's OmniActive Must Face US Patent Suit: Court
• Genzyme Hits Roxane With Suit Over Hectorol ANDA
• J&J Workers Renew Cert. Bid In Race Bias Action
• Colgate Sues J&J Over Total Trademark
• La. Told To Produce Docs In Zyprexa MDL
• Swath Of Claims Cut From Wellbutrin Antitrust Action
• FDA, EMEA Launch Clinical Trial Oversight Program
• Sun Pharma Settles Patent Suits Over Generic Ethyol
• House Panel Adds Pay-For-Delay Ban To Health Bill
• Clarcon Skin Products Seized Amid Bacteria Scare
• Thoratec, HeartWare Abandon Merger Talks
• GSK's Preemption Argument Fails To Stop Paxil Case
• Responding To Semi-Objectionable Discovery